Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

493.22
+10.152.10%
Post-market: 494.000.7800+0.16%19:59 EDT
Volume:1.50M
Turnover:740.33M
Market Cap:53.27B
PE:12.51
High:499.88
Open:485.54
Low:485.00
Close:483.07
Loading ...

Regeneron Says Libtayo Shows Strong Results in Adjuvant Skin Cancer Trial

MT Newswires Live
·
02 Jun

Truist Financial Reaffirms Their Buy Rating on Regeneron (REGN)

TIPRANKS
·
02 Jun

Regeneron Secures Global Rights to Novel GLP-1/GIP Receptor Agonist, Expanding Obesity Treatment Portfolio with Strategic In-Licensing from Hansoh Pharmaceuticals

Reuters
·
02 Jun

Regeneron Pharmaceuticals Inc - to Pay $80 Mln Upfront to Hansoh

THOMSON REUTERS
·
02 Jun

Regeneron Pharmaceuticals Inc: Potential Additional Payments of up to $1.93 Bln Under Deal

THOMSON REUTERS
·
02 Jun

Regeneron Expands Clinical-Stage Obesity Portfolio With Strategic in-Licensing of Novel Dual Glp-1/Gip Receptor Agonist

THOMSON REUTERS
·
02 Jun

Regeneron Pharmaceuticals Unveils Promising Phase 2 COURAGE Trial Results, Highlighting Enhanced Weight Loss with Muscle Preservation

Reuters
·
02 Jun

Interim Results From Ongoing Phase 2 Courage Trial Confirm Potential to Improve the Quality of Semaglutide (Glp-1 Receptor Agonist)-Induced Weight Loss by Preserving Lean Mass

THOMSON REUTERS
·
02 Jun

Regeneron Pharmaceuticals Inc: Combination of Semaglutide With Trevogrumab Was Generally Well-Tolerated

THOMSON REUTERS
·
02 Jun

Regeneron Pharmaceuticals Inc - 35% of Semaglutide-Induced Weight Loss Due to Lean Mass Loss

THOMSON REUTERS
·
02 Jun

Regeneron Pharmaceuticals Inc - Triplet Combination Had Higher Discontinuation Rate Due to Adverse Events

THOMSON REUTERS
·
02 Jun

Regeneron Pharmaceuticals Inc : Citigroup Cuts Target Price to $650 From $700

THOMSON REUTERS
·
02 Jun

RPT-BUZZ-US stocks weekly: Topsy-turvy

Reuters
·
02 Jun

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $750 From $896, Maintains Outperform Rating

MT Newswires Live
·
02 Jun

Regeneron Pharmaceuticals Inc : RBC Cuts to Sector Perform From Outperform; Cuts Target Price to $662 From $943

THOMSON REUTERS
·
02 Jun

U.S. RESEARCH ROUNDUP- Charter Communications, Ford, General Motors

Reuters
·
02 Jun

Regeneron Pharmaceuticals Inc : Jefferies Cuts Target Price to $804 From $914

THOMSON REUTERS
·
02 Jun

Regeneron announces analyses from Phase 3 C-Post trial

TIPRANKS
·
02 Jun

BRIEF-Regeneron Pharmaceuticals Inc Says Libtayo Shows 68% Reduction In Risk Of Disease Recurrence Or Death

Reuters
·
31 May

Regeneron Pharmaceuticals Inc - Libtayo Shows 65% Reduction in Distant Recurrence Risk

THOMSON REUTERS
·
31 May